Oxytocin and Borderline Personality Disorder

Borderline personality disorder (BPD) is a prevalent and severe mental disorder with affect dysregulation, impulsivity, and interpersonal dysfunction as its core features. Up to now, six studies have been performed to investigate the role of oxytocin in the pathogenesis of BPD. While a beneficial ef...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bertsch, Katja (VerfasserIn) , Herpertz, Sabine (VerfasserIn)
Dokumenttyp: Kapitel/Artikel
Sprache:Englisch
Veröffentlicht: 16 August 2017
In: Behavioral pharmacology of neuropeptides: Oxytocin
Year: 2017, Pages: 499-514
DOI:10.1007/7854_2017_26
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/7854_2017_26
Verlag, Volltext: https://link.springer.com/chapter/10.1007/7854_2017_26
Volltext
Verfasserangaben:Katja Bertsch, Sabine C. Herpertz

MARC

LEADER 00000caa a2200000 c 4500
001 1576086437
003 DE-627
005 20230523085635.0
007 cr uuu---uuuuu
008 180606s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/7854_2017_26  |2 doi 
035 |a (DE-627)1576086437 
035 |a (DE-576)506086437 
035 |a (DE-599)BSZ506086437 
035 |a (OCoLC)1341010890 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bertsch, Katja  |d 1981-  |e VerfasserIn  |0 (DE-588)141519568  |0 (DE-627)629442355  |0 (DE-576)324253478  |4 aut 
245 1 0 |a Oxytocin and Borderline Personality Disorder  |c Katja Bertsch, Sabine C. Herpertz 
264 1 |c 16 August 2017 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 06.06.2018 
520 |a Borderline personality disorder (BPD) is a prevalent and severe mental disorder with affect dysregulation, impulsivity, and interpersonal dysfunction as its core features. Up to now, six studies have been performed to investigate the role of oxytocin in the pathogenesis of BPD. While a beneficial effect of oxytocin on threat processing and stress responsiveness was found, other studies using an oxytocin challenge design presented with rather heterogeneous results. Future studies have to include a sufficiently large sample of patients, control for gender, and focus on mechanisms known to be related to aversive early life experiences. 
700 1 |a Herpertz, Sabine  |d 1960-  |e VerfasserIn  |0 (DE-588)132328526  |0 (DE-627)520581113  |0 (DE-576)182985261  |4 aut 
773 0 8 |i Enthalten in  |t Behavioral pharmacology of neuropeptides: Oxytocin  |d Cham : Springer International Publishing, 2018  |g (2017), Seite 499-514  |h Online-Ressource (IX, 593 Seiten)  |w (DE-627)1028028563  |w (DE-576)508127351  |z 9783319637396  |7 nnam  |a Oxytocin and Borderline Personality Disorder 
773 1 8 |g year:2017  |g pages:499-514  |g extent:16  |a Oxytocin and Borderline Personality Disorder 
856 4 0 |u http://dx.doi.org/10.1007/7854_2017_26  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/chapter/10.1007/7854_2017_26  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180606 
993 |a BookComponentPart 
994 |a 2017 
998 |g 132328526  |a Herpertz, Sabine  |m 132328526:Herpertz, Sabine  |d 910000  |d 910600  |e 910000PH132328526  |e 910600PH132328526  |k 0/910000/  |k 1/910000/910600/  |p 2  |y j 
998 |g 141519568  |a Bertsch, Katja  |m 141519568:Bertsch, Katja  |d 910000  |d 910600  |d 100000  |e 910000PB141519568  |e 910600PB141519568  |e 100000PB141519568  |k 0/910000/  |k 1/910000/910600/  |k 0/100000/  |p 1  |x j 
999 |a KXP-PPN1576086437  |e 3011736944 
BIB |a Y 
JSO |a {"name":{"displayForm":["Katja Bertsch, Sabine C. Herpertz"]},"id":{"eki":["1576086437"],"doi":["10.1007/7854_2017_26"]},"physDesc":[{"extent":"16 S."}],"recId":"1576086437","origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"16 August 2017"}],"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"edited-book"},"title":[{"title_sort":"Behavioral pharmacology of neuropeptides: Oxytocin","title":"Behavioral pharmacology of neuropeptides: Oxytocin"}],"origin":[{"publisher":"Springer International Publishing","dateIssuedDisp":"2018","publisherPlace":"Cham","dateIssuedKey":"2018"}],"person":[{"family":"Hurlemann","role":"edt","given":"René","display":"Hurlemann, René"},{"given":"Valéry","role":"edt","family":"Grinevich","display":"Grinevich, Valéry"}],"disp":"Oxytocin and Borderline Personality DisorderBehavioral pharmacology of neuropeptides: Oxytocin","physDesc":[{"extent":"Online-Ressource (IX, 593 Seiten)"}],"relMultPart":[{"recId":"870271490","dispAlt":"Current topics in behavioral neurosciences","disp":"Current Topics in Behavioral Neurosciences","origin":[{"dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisherPlace":"Heidelberg [u.a.]","publisher":"Springer"}],"pubHistory":["Nachgewiesen 18.2014 -"],"id":{"zdb":["2871405-2"],"eki":["870271490"]},"part":{"number_sort":["35"],"number":["volume 35"]},"title":[{"title":"Current topics in behavioral neurosciences","title_sort":"Current topics in behavioral neurosciences"}],"type":{"media":"Online-Ressource","bibl":"serial"},"language":["eng"]}],"recId":"1028028563","id":{"eki":["1028028563"],"isbn":["9783319637396"],"doi":["10.1007/978-3-319-63739-6"]},"part":{"extent":"16","text":"(2017), Seite 499-514","year":"2017","pages":"499-514"},"name":{"displayForm":["Rene Hurlemann, Valery Grinevich, editors"]}}],"person":[{"display":"Bertsch, Katja","family":"Bertsch","given":"Katja","role":"aut"},{"display":"Herpertz, Sabine","family":"Herpertz","role":"aut","given":"Sabine"}],"type":{"media":"Online-Ressource","bibl":"chapter"},"language":["eng"],"note":["Gesehen am 06.06.2018"],"title":[{"title":"Oxytocin and Borderline Personality Disorder","title_sort":"Oxytocin and Borderline Personality Disorder"}]} 
SRT |a BERTSCHKATOXYTOCINAN1620